{"contentid": 488712, "importid": NaN, "name": "UK study shows robust vaccine effectiveness against Indian strain", "introduction": "Real-world evidence from public health authorities in the UK suggests that coronavirus vaccines from Pfizer and BioNTech, and AstraZeneca, are effective against the so-called Indian variant.", "content": "<p><span style=\"font-weight: 400;\">Real-world evidence from public health authorities in the UK suggests that coronavirus vaccines from Pfizer (NYSE: PFE) and BioNTech (Nasdaq: BNTX), and AstraZeneca (LSE: AZN), are effective against the so-called Indian variant.</span></p>\n<p><span style=\"font-weight: 400;\">Researchers at Public Health England (PHE) </span><a href=\"https://khub.net/documents/135939561/430986542/Effectiveness+of+COVID-19+vaccines+against+the+B.1.617.2+variant.pdf/204c11a4-e02e-11f2-db19-b3664107ac42\"><span style=\"font-weight: 400;\">considered</span></a><span style=\"font-weight: 400;\"> vaccine effectiveness against symptomatic disease, with higher rates of protection to be expected against hospitalization and death.</span></p>\n<p><span style=\"font-weight: 400;\">Pfizer&rsquo;s mRNA-based vaccine, marketed as Comirnaty in Europe, provided 88% protection against the B.1.617.2 variant two weeks after a second dose, a level comparable with other strains of the virus.</span></p>\n<p><span style=\"font-weight: 400;\">The protection afforded by two doses of Vaxzevria, from AstraZeneca, was about 60% against this strain after two weeks.</span></p>\n<p><span style=\"font-weight: 400;\">The data show both vaccines are marginally less effective against B.1.617.2 than they are against the dominant strain in the UK, known as B.1.1.7, but researchers believe that immunity will continue to build over time.</span></p>\n<p><span style=\"font-weight: 400;\">In a statement, PHE said that &ldquo;other data on antibody profiles show it takes longer to reach maximum effectiveness with the AstraZeneca vaccine.&rdquo;</span></p>\n<p><span style=\"font-weight: 400;\">Commenting on the study British Health Secretary Matt Hancock said the evidence was &ldquo;ground-breaking,&rdquo; adding: &ldquo;We can now be confident that over 20 million people &ndash; more than one in three &ndash; have significant protection against this new variant.&rdquo;</span></p>\n<p><span style=\"font-weight: 400;\">PHE estimates that the COVID-19 vaccination program in the UK has so far prevented over 13,000 deaths and 39,000 hospitalizations in older people in England.</span></p>", "date": "2021-05-24 11:07:00", "meta_title": NaN, "meta_keywords": "vaccine, health, AstraZeneca, variant, Indian, protection, effectiveness, strain, public, evidence, effective, vaccines, study, Real-world, BioNTech, Pfize", "meta_description": "Real-world evidence from public health authorities in the UK suggest that coronavirus vaccines from Pfizer and BioNTech, and AstraZeneca, are effective against ", "meta_robots": NaN, "meta_display_in_sitemap": 1, "canonical_url": NaN, "status": 1, "access_status": 0, "ignore_flexible_sampling": 0, "display_start_date": "0000-00-00 00:00:00", "display_end_date": "0000-00-00 00:00:00", "display_in_search": 1, "created": "2021-05-24 11:05:49", "updated": "2021-05-24 12:46:37", "access": NaN, "url": "https://www.thepharmaletter.com/article/uk-study-shows-robust-vaccine-effectiveness-against-indian-strain", "description": NaN, "twitter_term": NaN, "twitter_widgetid": NaN, "key_facts": NaN, "news_snippet": NaN, "image1id": "lab_biotech_research_vaccine_big.jpg", "image2id": "lab_biotech_research_vaccine_small.jpg", "restrict_print": 0, "restrict_print_for_logged_out": 0, "box1_header": NaN, "box1_title": NaN, "box1_image1id": 0, "box1_url": NaN, "box1_introduction": NaN, "box1_position": 0, "tags": NaN, "sector_tag": "Biotechnology", "therapy area_tag": "Infectious diseases, Vaccines", "topic_tag": "Coronavirus, Focus On, Public health, Research", "geography_tag": "Germany, UK, USA", "company_tag": "AstraZeneca, BioNTech, Pfizer", "drug_tag": "Comirnaty, Vaxzevria", "market index_tag": NaN, "theme_tag": NaN, "industry sector_tag": NaN, "medical condition_tag": NaN, "industry term_tag": NaN, "organization_tag": NaN, "person_tag": NaN, "position_tag": NaN, "medical treatment_tag": NaN, "facility_tag": NaN, "technology_tag": NaN, "journalist_tag": NaN, "published medium_tag": NaN, "political event_tag": NaN, "anniversary_tag": NaN, "sports event_tag": NaN, "movie_tag": NaN, "fax number_tag": NaN, "currency pair_tag": NaN, "sports league_tag": NaN, "date_tag": NaN, "music group_tag": NaN, "phone number_tag": NaN, "t v show_tag": NaN, "t v station_tag": NaN, "entertainment award event_tag": NaN, "industry_tag": NaN, "pharmaceutical drug_tag": NaN, "topmost public parent company_tag": NaN, "content_type_name": "Article", "pubDate": "2021-05-24 11:07:00"}